The induction of cell cycle regulatory and DNA repair proteins in cisplatin-induced acute renal failure

Toxicology and Applied Pharmacology

Volumn 200, Issue 2, 2004, Pages 111-120

  Zhou, Hua ^a   Kato, Akihiko ^a,b   Yasuda, Hideo ^a   Miyaji, Takehiko ^a   Fujigaki, Yoshihida ^a   Yamamoto, Tatsuo ^a   Yonemura, Katsuhiko ^a   Hishida, Akira ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Acute renal failure; Cisplatin; Cyclin B1; Cyclin D1; GADD; p27; PCNA

Indexed keywords

ARSENITE SODIUM; CISPLATIN; CREATININE; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HEAVY METAL; PROTEIN; PROTEIN P21; PROTEIN P27; REGULATOR PROTEIN;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL CYCLE; CELL DAMAGE; CELL NUCLEUS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DNA REPAIR; EVALUATION; KIDNEY CELL; KIDNEY MEDULLA; KIDNEY TUBULE DAMAGE; MALE; NEPHROTOXICITY; NICK END LABELING; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENITES; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEINS; CELL CYCLE PROTEINS; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA REPAIR; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KIDNEY FAILURE, ACUTE; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY; SODIUM COMPOUNDS; TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 5144223523     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2004.04.003     Document Type: Article

References (43)

1. Akervall J., Brun E., Dictor M., Wennerberg J. Cyclin D1 overexpression versus response to induction chemotherapy in squamous cell carcinoma of the head and neck - Preliminary report. Acta Oncol. 40:2001;505-511
2. Bedi A., Barber J.P., Bedi G.C., el-Deiry W.S., Sidransky D., Vala M.S., Akhtar A.J., Hilton J., Jones R.J. BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. Blood. 86:1995;1148-1158
3. Casanovas O., Miro F., Estanyol J.M., Itarte E., Agell N., Bachs O. Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner. J. Biol. Chem. 275:2000;35091-35097
4. Celis J.E., Madsen P. Increased nuclear cyclin/PCNA antigen staining of non S-phase transformed human amnion cells engaged in nucleotide excision DNA repair. FEBS Lett. 209:1986;277-283
5. Chou R.H., Huang H. Restoration of p53 tumor suppressor pathway in human cervical carcinoma cells by sodium arsenite. Biochem. Biophys. Res. Commun. 293:2002;298-306
6. Dan S., Yamori T. Repression of cyclin B1 expression after treatment with adriamycin, but not cisplatin in human lung cancer A549 cells. Biochem. Biophys. Res. Commun. 280:2001;861-867
7. Delmastro D.A., Li J., Vaisman A., Solle M., Chaney S.G. DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines. Cancer Chemother. Pharmacol. 39:1997;245-253
8. Dhanalakshmi S., Agarwal P., Glode L.M., Agarwal R. Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death. Int. J. Cancer. 106:2003;699-705
9. Dimanche-Boitrel M.T., Micheau O., Hammann A., Haugg M., Eymin B., Chauffert B., Solary E. Contribution of the cyclin-dependent kinase inhibitor p27KIP1 to the confluence-dependent resistance of HT29 human colon carcinoma cells. Int. J. Cancer. 77:1998;796-802
10. Fan S., Chang J.K., Smith M.L., Duba D., Fornace A.J. Jr., O'Connor P.M. Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard. Oncogene. 14:1997;2127-2136
11. Gillett C.E., Barnes D.M., Camplejohn R.S. Comparison of three cell cycle associated antigens as markers of proliferative activity and prognosis in breast carcinoma. J. Clin. Pathol. 46:1993;1126-1128
12. Hughes P.E., Alexi T., Yoshida T., Schreiber S.S., Knusel B. Excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes Bax and Gadd-45 in brain areas showing DNA fragmentation. Neuroscience. 74:1996;1143-1160
13. Hyun P.W., Hee C.Y., Won J.C., Oh P.J., Kim K.K., Hyuck I.Y., Lee M.H., Kang W., Park K. Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis. Biochem. Biophys. Res. Commun. 300:2003;230-235
14. Jeong J.K., Dybing E., Soderlund E., Brunborg G., Holme J.A., Lau S.S., Monks T.J. DNA damage, gadd153 expression, and cytotoxicity in plateau-phase renal proximal tubular epithelial cells treated with a quinol thioether. Arch. Biochem. Biophys. 341:1997;300-308
15. Johnston D., Oppermann H., Jackson J., Levinson W. Induction of four proteins in chick embryo cells by sodium arsenite. J. Biol. Chem. 255:1980;6975-6980
16. Johnsson A., Strand C., Los G. Expression of GADD153 in tumor cells and stromal cells from xenografted tumors in nude mice treated with cisplatin: correlations with cisplatin-DNA adducts. Cancer Chemother. Pharmacol. 43:1999;348-352
17. Latif C., Harvey S.H., O'Connell J. Ensuring the stability of the genome: DNA damage checkpoints. Sci. World J. 1:2001;684-702
18. Li X., Ding X., Adrian T.E. Arsenic trioxide induces apoptosis in pancreatic cancer cells via changes in cell cycle, caspase activation, and GADD expression. Pancreas. 27:2003;174-179
19. Lin Z., Lim S., Viani M.A., Sapp M., Lim M.S. Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents. Am. J. Pathol. 159:2001;711-719
20. Matsunobu T., Tanaka K., Matsumoto Y., Nakatani F., Sakimura R., Hanada M., Li X., Oda Y., Naruse I., Hoshino H., Tsuneyoshi M., Miura H., Iwamoto Y. The prognostic and therapeutic relevance of p27kip1 in Ewing's family tumors. Clin. Cancer Res. 10:2004;1003-1012
21. Megyesi J., Safirstein R.L., Price P.M. Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J. Clin. Invest. 101:1998;777-782
22. Miyaji T., Kato A., Yasuda H., Fujigaki Y., Hishida A. Role of the increase in p21 in cisplatin-induced acute renal failure in rats. J. Am. Soc. Nephrol. 12:2001;900-908
23. Nakashima T., Clayman G.L. Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinoma. Arch. Otolaryngol., Head Neck Surg. 126:2000;957-961
24. O'Connor P.M. Mammalian G1 and G2 phase checkpoints. Cancer Surv. 29:1997;151-182
25. Ophascharoensuk V., Fero M.L., Hughes J., Roberts J.M., Shankland S.J. The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury. Nat. Med. 4:1998;575-580
26. Oshita F., Kameda Y., Nishio K., Tanaka G., Yamada K., Nomura I., Nakayama H., Noda K. Increased expression levels of cyclin-dependent kinase inhibitor p27 correlate with good responses to platinum-based chemotherapy in non-small cell lung cancer. Oncol. Rep. 7:2000;491-495
27. Owa T., Yoshino H., Yoshimatsu K., Nagasu T. Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr. Med. Chem. 8:2001;1487-1503
28. Pines J., Hunter T. Cyclins A and B1 in the human cell cycle. Ciba Found. Symp. 170:1992;187-196
29. Ruan S., Okcu M.F., Ren J.P., Chiao P., Andreeff M., Levin V., Zhang W. Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. Cancer Res. 58:1998;1538-1543
30. Sato N., Mizumoto K., Maehara N., Kusumoto M., Nishio S., Urashima T., Ogawa T., Tanaka M. Enhancement of drug-induced apoptosis by antisense oligodeoxynucleotides targeted against Mdm2 and p21WAF1/CIP1. Anticancer Res. 20:2000;837-842
31. Schwartz D., Almog N., Peled A., Goldfinger N., Rotter V. Role of wild type p53 in the G2 phase: regulation of the gamma-irradiation-induced delay and DNA repair. Oncogene. 15:1997;2597-2607
32. Shankland S.J. The growing role for the cyclin kinase inhibitor p27Kip1 in renal disease. Kidney Int. 54:1998;2241-2242
33. Shankland S.J., Wolf G. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am. J. Physiol.: Renal. Physiol. 278:2000;F515-F529
34. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1999;1501-1512
35. Simeonova P.P., Wang S., Toriuma W., Kommineni V., Matheson J., Unimye N., Kayama F., Harki D., Ding M., Vallyathan V., Luster M.I. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res. 60:2000;3445-3453
36. Sugiyama K., Akiyama T., Shimizu M., Tamaoki T., Courage C., Gescher A., Akinaga S. Decrease in susceptibility toward induction of apoptosis and alteration in G1 checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-Hydroxystaurosporine). Cancer Res. 59:1999;4406-4412
37. Tomasevic G., Kamme F., Stubberod P., Wieloch M., Wieloch T. The tumor suppressor p53 and its response gene p21WAF1/Cip1 are not markers of neuronal death following transient global cerebral ischemia. Neuroscience. 90:1999;781-792
38. Wang Y., Blandino G., Oren M., Givol D. Induced p53 expression in lung cancer cell line promotes cell senescence and differentially modifies the cytotoxicity of anti-cancer drugs. Oncogene. 17:1998;1923-1930
39. Wang M.B., Yip H.T., Srivatsan E.S. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin. Laryngoscope. 111:2001;982-988
40. Yang C.W., Kim B.S., Kim J., Ahn H.J., Park J.H., Jin D.C., Kim Y.S., Bang B.K. Preconditioning with sodium arsenite inhibits apoptotic cell death in rat kidney with ischemia/reperfusion or cyclosporine-induced injuries. Exp. Nephrol. 9:2001;284-294
41. Yoshii T., Fukumori T., Honjo Y., Inohara H., Kim H.R., Raz A. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J. Biol. Chem. 277:2002;6852-6857
42. Zhang Z., Yang X.Y., Cohen D.M. Urea-associated oxidative stress and Gadd153/CHOP induction. Am. J. Physiol.: Renal. Physiol. 276:1999;F786-F793
43. Zhou H., Kato A., Yasuda H., Odamaki M., Itoh H., Hishida A. The induction of heat shock protein72 attenuates cisplatin-induced acute renal failure in rats. Pflüegers Arch. 446:2003;116-124